MedTrace Logo

Intima-Medial Thickness Guidance of Primary Prevention in Relatives of Patients With Early onSet Atherosclerosis

NCT01330602 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1310

Last updated 2013-10-10

No results posted yet for this study

Summary

The primary objective of this study is, to instigate a reduction in atherosclerotic burden within the carotid arteries in the intervention group compared to the control group and to demonstrate parallel improvements in cardiovascular and overall health status relative to usual care

Conditions

Interventions

BEHAVIORAL

IMPRESS intervention

The key elements of the IMPRESS intervention include: * Promoting a healthy lifestyle * Supporting lifestyle and risk modification * Encouraging active self-management of risk and chronic disease * Improving coordination of care * Pharmacological therapy

Sponsors & Collaborators

Principal Investigators

  • Desley G HEGNEY, Professor · National University Health system, NUS

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01330602 on ClinicalTrials.gov